Metabolic Status of Patients with Hypoestrogenic Anovulation on the Long-Term Hormone Replacement Therapy
Metabolic Status of Patients with Hypoestrogenic Anovulation on the Long-Term Hormone Replacement Therapy
Journal of Hospital and Clinical Pharmacy (Research & Reviews Publishing S.L) is an open access peer-reviewed journal that aims in assisting Researchers to stay abreast of key advances and to publish the latest and outstanding Research articles, reviews, and letters in all the areas of both hospital pharmacy and clinical pharmacy. It covers a broad range of topics including but not limited to Drugs & Drug information studies, General anaesthesia, Automatized anaesthesia, Paediatric Anaesthesia, Neuro anaesthesia, All kind of surgeries General medicine & Critical care medicine, Pain management, Drug information studies, Clinical reviews, Pharmacy practices, Patient care & Counselling, Clinical trials, Patient management, Patient care, Nursing, Disease and hospitalization etc.
It gives us great pleasure to announce the call for paper of the Journal at special and hefty discount of up to 50 percent on one-time article processing charge. Prospective academicians and scientists are encouraged to utilize this opportunity to get their articles reviewed, processed and published at relatively faster pace and at lower charges. In addition to this, the authors who publish with us during the year-long celebrations will also be eligible for academic awards recommended by the editorial panel.
The Archive page contains wide variety of articles such as Research / Review / Case reports / short communication / Mini review / Prospective / Letter to Editors Etc. We would like introduce a Research Article which has been disseminated to the widest audience of experts; and thus increased in readership, citations.
Abstract: 27 patients with hypoestrogenic anovulation (11 – hypogonadotropic hypogonadism (HH) and 16 - premature ovarian failure (POF) have been observed for more than 5 (6.9 ± 1.8) years. The average age at the end of the study HH patients was 28.5 ± 4.9 years, with POF – 36.3 ± 6.4 years. Estradiol/dydrogesterone (E2/D) was used in 11 patients (n=4 – HH; n=7 – POF) Estradiol valerate/levonorgestrel (EV/LNG) – 16 patients (n=7 – HH; n=9 – POF). The prevalence of insulin resistance has increased significantly 26 (92.3%) vs. 20 (74.1%) χ2 A/D p<0.01). Stepwise regression method is carried out to find the most significant predictor of deterioration insulin sensitivity in patients with hypoestrogenism on a long-term hormone replacement therapy (HRT). Analysis of the cumulative effect of each other such factors as: the choice of medicine for HRT, age, BMI at the end of the study, triglyceride levels, family anamnesis of type 2 diabetes (T2D), has determined the leading predictor of increasing index HOMA only family anamnesis of T2D (R=0.92; p=0.00). The frequency of hypertriglyceridemia has also increased significantly (9 (33.3%) vs. 6(22.2%) χ2 A/D p<0.05). The main predictor of growth hypertriglyceridemia recognized age of women at the end of the study (R=0.49; p<0.05), but the choice of the medicine. The number of women with impaired glucose tolerance increased to 14.8% (vs. 0%) χ2 A/D 21.0; p<0.001). Predictors of IGT (T2D) patients with hypoestrogenism on the long-term HRT called HOMA index (R=0.74; p<0.01) and anamnesis for T2D (R=0.76; p<0.001). HRT does not protect the deterioration of insulin sensitivity in patients with a family anamnesis of T2D and is not a means of prevention of this disease.
To have a glance at the full length manuscript, you can visit us at our archive page and Currently, Journal’s Archive is holding not only normal issues but also focusing on special issues. The purpose of special issues is to publish the most exciting research with respect to the subjects of Hospital and Clinical Pharmacy and to provide a rapid turn-around time regarding reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes. Submit manuscript of your research articles or special issue articles online through manuscript submission or forwarded to the Editorial Office at clinpharmacy@journaloa.org
Point of Contact,
John Robert
Managing Editor
Email: clinpharmacy@journaloa.org
Whatsapp: +44-20-3608-4181
Research & Reviews: Journal of Hospital and Clinical Pharmacy